71.93 16.05 39.39 22.83 75.73 16.64 (50.65) (70.42) Note: The ratio in the income statement is presented as a percentage of total income. The cost of sales of real estate is shown as a percentage of
financial statement of the Company and its subsidiaries as at March 31, 2020 4 Note : 1 and 2 The company inform the Stock Exchange of Thailand on 22 April 2020. No. Contract No. Borrower Lender Appro ved
4,119,125 The total transaction from the period October 2020 to December 2020 is the amount of 4,119,125 Baht. Name, position and shareholding proportion of the connected persons. Note: 1Mr.Kazumasa Oshima is
profit margin 2.70% 46.22% (43.52%) DOD BIOTECH PUBLIC COMPANY LIMITED 111 Moo 2 TambonThachin, Amphurmuangsamutsakhon, Samutsakhon 74000 Page 2 * Note the financial statements for the 3rd quarter ended
# -,.) @)ก ก #A B + NF/ ## *8##(E/ก# ## E +* (non P investment grade) 70/ / ## ++* 8ก# A**8##(E (Unrated) ?*,A0+ B + NF/ ## #N #, #7G (Structured Note) ก A0( # #N #, # (Derivatives) ?*, /E 0.(- ก
Case number 269/2563 (detailed in Note to the Financial Statements No.26) 4. Financial costs, amount Baht 4.80 million, decrease Baht 2.40 million or 33.26 percent because the Company has redeemed the
$ -,.) B)ก ก $C D + OH/ $$ *:$$(G/ก$ $$ G +* (non Q investment grade) 90/ / $$ ++* :ก$ C**:$$(G (Unrated) A*,C0+ D + OH/ $$ $O $, $9I (Structured Note) ก C0( $ $O $, $ (Derivatives) A*, /G 0.(- ก
$ -,.) @)ก ก $A B + NF/ $$ *9$$(E/ก$ $$ E +* (non P investment grade) 80/ / $$ ++* 9ก$ A**9$$(E (Unrated) ?*,A0+ B + NF/ $$ $N $, $8G (Structured Note) ก A0( $ $N $, $ (Derivatives) ?*, /E 0.(- ก
%C D , NJ/ %% +9%%#I/ก% %% I ,+ (non P investment grade) 82/ / %% ,,+ 9ก% C++9%%#I (Unrated) A+&C2, D , NJ/ %% %N %& %8G (Structured Note) • ก& B.Dก% 9 *% ก : ก ก& B.ก% #+ & (buy-and-hold